StockData
Veradermics, Inc logo

Veradermics, Inc (MANE) stock

MANENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$135.29−21.27 (-13.59%)

Close on Nov 12, 2026Market cap $5.65BP/E –Yield –

Veradermics statistics

55 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 29, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$5.65B
$280.48M
Enterprise Value
$4.85B
$148.62M
PB Ratio
7.10
2.05
P/TBV Ratio
7.10
2.29

Share statisticsIndustry

Shares Change (QoQ)
0.97%
0.48%
Float
26M
49M
Shares Held by Insiders
38.4%
12.1%
Shares Held by Institutions
81.6%
56.4%

Short sellingIndustry

Short Interest
3M
–
Short Interest Change
-8.36%
-0.76%
Short % of Float
13.2%
9.06%
Short % of Shares Outstanding
8.11%
6.30%
Days to Cover
5.06
5.13

Stock price statisticsIndustry

20-Day Moving Average
$136.44
–
50-Day Moving Average
$121.59
–
Average True Range (14)
$10.11
–
Price Change (1 Week)
5.20%
1.51%
Price Change (1 Month)
19.2%
-2.37%
Price Change (3 Months)
20.0%
-21.1%
Price Change (6 Months)
27.5%
-22.8%
Average Volume (10 Days)
760,317
–
Average Volume (20 Days)
725,579
–
Average Volume (90 Days)
765,016
–
Relative Volume
3.10
0.80
Relative Strength Index (14)
51.3
44.7
Volatility (1 Year)
92.8%
80.2%

Returns on capitalIndustry

Return on Equity (ROE)
-26.7%
-51.3%
Return on Assets (ROA)
-11.6%
-40.7%
Return on Capital Employed (ROCE)
-14.0%
-38.1%

Financial positionIndustry

Current Ratio
77.68
3.31
Quick Ratio
76.97
2.41

EfficiencyIndustry

Profits Per Employee
-$4.46M
-$683.67K
Employee Count
21
75

Income statement (TTM)Industry

Operating Income
-$111.21M
-$20.99M
Pretax Income
-$93.58M
-$13.23M
Net Income
-$93.58M
-$21.61M
EBITDA
-$111.21M
-$16.85M
EPS (Diluted)
-$40.02
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$798.40M
$16.98M
Net Cash Per Share
$19.11
$0.72
Equity (Book Value)
$796.47M
$52.68M
Book Value Per Share
$19.06
$1.50
Tangible Book Value
$796.47M
$26.74M
Working Capital
$795.41M
$78.52M

Cash flow (TTM)Industry

Operating Cash Flow
-$82.23M
-$12.27M
Capital Expenditures
-$372.00K
-$944.00K
Free Cash Flow
-$82.60M
-$18.20M
FCF Per Share
-$1.98
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-1.66%
-21.0%
FCF Yield
-1.46%
-9.44%

Taxes and interestIndustry

Income Tax
$0
$74.00K

Scores and fair valueIndustry

Altman Z-Score
316.05
0.26
Piotroski F-Score
3
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodMANES&P 500DifferenceMANE per yearS&P 500 per year
1 month+10.5%-2.7%+13.2 pts
3 months+24.1%-1.7%+25.8 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M MANE shares were sold short on Oct 30, 2026, down 8.4% from the previous report, or 13.17% of the shares available to trade. At recent volumes it would take 5.1 days to buy them back. Over the last 20 sessions, 62.0% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20263,389,250-8.4%670,3145.1
Oct 15, 20263,698,387-12.9%982,2323.8
Sep 30, 20264,244,476+3.3%907,0334.7
Sep 15, 20264,106,974+2.0%549,3957.5
Aug 31, 20264,025,420+0.3%608,6746.6
Aug 14, 20264,011,753-16.8%1,002,5684.0
Jul 31, 20264,820,395+22.5%696,5456.9
Jul 15, 20263,936,348+3.3%560,6257.0
Jun 30, 20263,810,334+52.9%1,072,2133.5
Jun 15, 20262,492,695+5.5%418,0006.0
May 29, 20262,363,440+15.3%489,8994.8
May 15, 20262,050,182-0.4%632,1503.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?